Login
From:
Insider Monkey
(Uncensored)
subscribe
Guggenheim Initiates Olema Pharmaceuticals (OLMA) Coverage with Buy Rating and $20 PT, Cites Palazestrant Potential - Insider Monkey
https://www.insidermonkey.com/blog/guggenheim-initiates-olema-pharmaceuticals-olma-coverage-with-buy-rating-and-20-pt-cites-palazestrant-potential-1628061/
links
backlinks
Tagged with:
news
yahoo finance
nasdaq olma
olema pharmaceuticals inc.
Olema Pharmaceuticals Inc. (NASDAQ:OLMA) is one of the best hot stocks to invest in. On October 8, Guggenheim initiated coverage of Olema Oncology with a Buy rating and $20 price target.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
